Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Coeptis Therapeutics Holdings Inc (COEP)

  7. Coeptis Therapeutics Holdings Inc (COEP) Financials

COEP

Coeptis Therapeutics Holdings Inc

1.55
-0.14 (-8.28%)
Upgrade to Real-Time

Coeptis Therapeutics Holdings Inc. (COEP) Fundamentals
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.
SHARE INFORMATION
Market Cap$ 34,545,351
Shares Outstanding20,441,036
Float15,439,600
Percent Float75.53%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.63
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions21
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months55,714
Institutional Holdings Percent19.8%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months1,175,000
Insider Holdings Percent26.0
Insider Sold Previous 3 Months-
Insider Shares Owned5,322,521
TRADING INFO
52 Week High$ 21.42
52 Week Low$ 1.03
52 Week High Change$ -83.20
21 Day Moving Average$ 1.7179
21 Day Extended Moving Average$ 1.7534
50 Day Moving Average$ 1.5264
50 Day Extended Moving Average$ 1.6394
200 Day Moving Average$ 3.9497
200 Day Extended Moving Average$ 3.5888
10 Day Average Volume167,199
20 Day Average Volume126,227
30 Day Average Volume115,549
50 Day Average Volume437,277
Alpha-0.026564
Beta-0.5895
Standard Deviation0.198746
R20.022896
7 Day Price Change$ -0.32
7 Day Percent Change-15.92%
21 Day Price Change$ 0.14
21 Day Percent Change9.03%
30 Day Price Change$ 0.45
30 Day Percent Change36.29%
Month to Date Price Change$ -0.205
Month to Date Percent Change-10.82%
Quarter to Date Price Change$ 0.25
Quarter to Date Percent Change17.36%
180 Day Price Change$ -0.39
180 Day Percent Change-18.75%
200 Day Price Change$ -0.5977
200 Day Percent Change-26.13%
Year to Date Price Change$ 0.1587
Year to Date Percent Change10.36%

Coeptis Therapeutics Holdings Inc. (COEP) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.00
Leverage Ratio0.00
Quick Ratio0.00
Long Term Debt To Capital0.11
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 23,875,154
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book-0.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets0.00
Return on Equity0.00
Return on Capital0.00

Coeptis Therapeutics Holdings Inc. (COEP) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEODavid Mehalick
Employees-
Last Audit-
CIK0001759186
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address
Suite 420
,
Website
Facsimile-
Telephone-
Email-


Your Recent History
NASDAQ
COEP
Coeptis Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.